We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

YJ:NASDAQYunji Inc. - American Depository Shares Analysis

Data as of 2026-08-22 - not real-time

$3.61

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Yunji Inc. is priced at $3.61 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 149.0%. Relative strength is 65.4 — approaching overbought — and the MACD signal is bullish. Recent trading has carved out support near $1.18 and resistance around $13.97.
Valuation screens as fair, on a P/E of 36.1 with no clean sector comparison available. Revenue is contracting at 39.2% on a -41.2% profit margin.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 413.5%, a beta of 0.38 and a maximum drawdown of 51.3%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

HANGZHOU, China, Aug. 13, 2026 /PRNewswire/ -- Yunji Inc. 'Yunji' or the 'Company' NASDAQ: YJ , a leading...HANGZHOU, China, Aug. 20, 2026 /PRNewswire/ -- Yunji Inc. 'Yunji' or the 'Company' NASDAQ: YJ , a leading...HANGZHOU, China, Aug. 20, 2026 /PRNewswire/ -- Yunji Inc. "Yunji" or the "Company" NASDAQ: YJ , a leading...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 1.61
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 1.61
  • 30-day volatility of 413.5%

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Negative profit margin of -41.2%
  • Negative return on equity of -11.5%
  • Revenue contracting at -39.2%

Key Metrics & Analysis

Financial Health

Revenue Growth-39.20%
Profit Margin-41.17%
P/E Ratio36.1
ROE-11.48%
ROA-5.76%
Debt/Equity14.57
P/B Ratio0.1

Technical Analysis

TrendBullish
RSI65.4
Support$1.18
Resistance$13.97
MA 20$2.04
MA 50$1.70
MA 200$1.61
MACDBullish
VolumeIncreasing
Fear & Greed Index94.41

Valuation

GradeFair
TypeBlend

Risk Assessment

Beta0.38
Volatility413.55%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.